Detalhe da pesquisa
1.
Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial.
Tumour Biol
; 40(3): 1010428318764007, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29534639
2.
In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma Cells.
Onco Targets Ther
; 15: 1291-1307, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36310770
3.
Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.
Viruses
; 13(8)2021 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452286
4.
Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing.
Front Oncol
; 9: 425, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31192129
5.
Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.
Ann N Y Acad Sci
; 1434(1): 342-359, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29917250
6.
Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.
Eur J Cancer
; 59: 160-170, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27039171
7.
Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1.
Front Oncol
; 4: 92, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24822170
8.
Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells.
Onco Targets Ther
; 6: 1119-27, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23986643